Revenue
2020
2021
2022
2023
2024
2025
Rani Therapeutics Holdings, Inc. (RANI)
Price—Loading quote
Net income
2020
2021
2022
2023
2024
2025
Free cash flow
2020
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Revenue | $1.6M | $1.0M | $0 | $0 | $2.7M | $462,000 |
| Research & development | $20.2M | $26.7M | $39.6M | $36.6M | $26.5M | $12.0M |
| Operating expenses | $39.9M | $54.3M | $66.1M | $63.5M | $54.3M | — |
| Operating income | −$38.3M | −$53.3M | −$66.1M | −$63.5M | −$51.6M | −$16.5M |
| EBITDAderived | −$37.4M | −$52.3M | −$65.3M | −$62.9M | −$51.1M | — |
| Net income | −$29.7M | −$30.0M | −$34.0M | −$30.6M | −$8.3M | −$16.7M |
| Basic EPSper diluted share | -$0.45 | -$1.05 | -$1.33 | -$1.28 | -$0.43 | — |
| Diluted EPSper diluted share | -$0.45 | -$1.05 | -$1.33 | -$1.28 | -$0.43 | — |
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Oct 23, 2025Form 4 | IMRAN MIR ADirector,TenPercentOwner | BuyClass A Common Stock | 2.08M | $0.61 | $1.27M | 2.08M |
| Oct 23, 2025Form 4 | IMRAN MIR ADirector,TenPercentOwner | BuyWarrant to Purchase Class A Common Stock · derivative | 2.08M | $0.00 | $0.00 | 2.08M |
| Oct 21, 2025Form 4 | South Cone Investments Limited PartnershipTenPercentOwner | SellClass A Common Stock · indirect | 4.00M | $2.77 | $11.08M | 2.38M |
| Oct 20, 2025Form 4 | South Cone Investments Limited PartnershipTenPercentOwner | SellClass A Common Stock · indirect | 1.92M | $2.41 | $4.63M | 6.38M |
| Dec 13, 2024Form 4 | McKinley KateChief Business Officer | BuyClass A Common Stock | 18.0K | $1.67 | $30.0K | 18.0K |